Global Artificial Intelligence (AI) in Cancer Market Growth (Status and Outlook) 2026-2032
The global Artificial Intelligence (AI) in Cancer market size is predicted to grow from US$ 2353 million in 2025 to US$ 8085 million in 2032; it is expected to grow at a CAGR of 19.3% from 2026 to 2032.
Artificial Intelligence (AI) in Cancer refers to the application of machine learning, deep learning, and data-driven computational models across the oncology care continuum to support cancer screening, diagnosis, treatment planning, and outcome prediction. AI systems in oncology analyze large volumes of heterogeneous data, including medical imaging, digital pathology slides, genomic and multi-omics data, and real-world clinical records, to detect patterns that exceed human cognitive limits. In clinical practice, these solutions function primarily as decision-support tools, improving diagnostic accuracy, standardizing interpretation, accelerating workflows, and enabling more personalized treatment strategies. Rather than replacing oncologists, AI augments clinical expertise by reducing variability and supporting earlier and more consistent cancer detection and management.
From a multi-angle classification and parameterization perspective, the market can be segmented by clinical application stage (screening and early detection, diagnosis and classification, treatment planning, therapy monitoring, and prognosis), by data modality (imaging-based, pathology-based, genomics-based, clinical data-driven, or multimodal fusion), and by cancer type (lung, breast, colorectal, prostate, hematologic, and rare cancers). Additional parameters that differentiate solutions include sensitivity and specificity at defined clinical thresholds, explainability of AI outputs, integration with hospital IT systems, regulatory clearance status, and scalability across institutions and geographies.
The industry value chain begins upstream with data generation and infrastructure providers, including imaging equipment manufacturers, sequencing platforms, digital pathology scanners, and cloud computing services. Midstream players consist of AI oncology solution developers that curate datasets, train models, and package algorithms into regulated software or integrated platforms. Downstream customers include hospitals, cancer centers, diagnostic laboratories, pharmaceutical companies, and population-level screening programs, often adopting AI tools through enterprise licenses or software-as-a-service models.
From a profitability standpoint, AI in Cancer solutions typically exhibit gross margins in the 65–85% range, reflecting their software-centric economics once development and regulatory costs are absorbed. Cloud-based platforms and AI-as-a-service models tend to achieve the highest margins, while device-embedded solutions trade some margin for faster adoption through OEM partnerships. Market growth is driven by rising cancer incidence, shortages of oncology specialists, increasing data complexity, and the shift toward precision medicine. Key trends include multimodal data integration, expansion from detection to outcome prediction, deeper OEM and hospital integration, and growing use of AI to support value-based oncology care.
LPI (LP Information)' newest research report, the “Artificial Intelligence (AI) in Cancer Industry Forecast” looks at past sales and reviews total world Artificial Intelligence (AI) in Cancer sales in 2025, providing a comprehensive analysis by region and market sector of projected Artificial Intelligence (AI) in Cancer sales for 2026 through 2032. With Artificial Intelligence (AI) in Cancer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Intelligence (AI) in Cancer industry.
This Insight Report provides a comprehensive analysis of the global Artificial Intelligence (AI) in Cancer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Artificial Intelligence (AI) in Cancer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Intelligence (AI) in Cancer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Intelligence (AI) in Cancer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Intelligence (AI) in Cancer.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Intelligence (AI) in Cancer market by product type, application, key players and key regions and countries.
Segmentation by Type:
Artificial Intelligence (AI) in Cancer refers to the application of machine learning, deep learning, and data-driven computational models across the oncology care continuum to support cancer screening, diagnosis, treatment planning, and outcome prediction. AI systems in oncology analyze large volumes of heterogeneous data, including medical imaging, digital pathology slides, genomic and multi-omics data, and real-world clinical records, to detect patterns that exceed human cognitive limits. In clinical practice, these solutions function primarily as decision-support tools, improving diagnostic accuracy, standardizing interpretation, accelerating workflows, and enabling more personalized treatment strategies. Rather than replacing oncologists, AI augments clinical expertise by reducing variability and supporting earlier and more consistent cancer detection and management.
From a multi-angle classification and parameterization perspective, the market can be segmented by clinical application stage (screening and early detection, diagnosis and classification, treatment planning, therapy monitoring, and prognosis), by data modality (imaging-based, pathology-based, genomics-based, clinical data-driven, or multimodal fusion), and by cancer type (lung, breast, colorectal, prostate, hematologic, and rare cancers). Additional parameters that differentiate solutions include sensitivity and specificity at defined clinical thresholds, explainability of AI outputs, integration with hospital IT systems, regulatory clearance status, and scalability across institutions and geographies.
The industry value chain begins upstream with data generation and infrastructure providers, including imaging equipment manufacturers, sequencing platforms, digital pathology scanners, and cloud computing services. Midstream players consist of AI oncology solution developers that curate datasets, train models, and package algorithms into regulated software or integrated platforms. Downstream customers include hospitals, cancer centers, diagnostic laboratories, pharmaceutical companies, and population-level screening programs, often adopting AI tools through enterprise licenses or software-as-a-service models.
From a profitability standpoint, AI in Cancer solutions typically exhibit gross margins in the 65–85% range, reflecting their software-centric economics once development and regulatory costs are absorbed. Cloud-based platforms and AI-as-a-service models tend to achieve the highest margins, while device-embedded solutions trade some margin for faster adoption through OEM partnerships. Market growth is driven by rising cancer incidence, shortages of oncology specialists, increasing data complexity, and the shift toward precision medicine. Key trends include multimodal data integration, expansion from detection to outcome prediction, deeper OEM and hospital integration, and growing use of AI to support value-based oncology care.
LPI (LP Information)' newest research report, the “Artificial Intelligence (AI) in Cancer Industry Forecast” looks at past sales and reviews total world Artificial Intelligence (AI) in Cancer sales in 2025, providing a comprehensive analysis by region and market sector of projected Artificial Intelligence (AI) in Cancer sales for 2026 through 2032. With Artificial Intelligence (AI) in Cancer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Intelligence (AI) in Cancer industry.
This Insight Report provides a comprehensive analysis of the global Artificial Intelligence (AI) in Cancer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Artificial Intelligence (AI) in Cancer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Intelligence (AI) in Cancer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Intelligence (AI) in Cancer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Intelligence (AI) in Cancer.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Intelligence (AI) in Cancer market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Medical Imaging–based AI
- Digital Pathology–based AI
- Genomics & Multi-omics AI
- Others
- Detection & Flagging
- Segmentation & Quantification
- Classification & Grading
- Prediction & Outcome Modeling
- Others
- Device-embedded AI Systems
- Standalone Software / SaaS Platforms
- AI-as-a-Service for Oncology
- Others
- Lung Cancer
- Breast Cancer
- Colorectal & GI Cancers
- Prostate & Urological Cancers
- Hematologic & Rare Cancers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- PathAI
- PaigeAI
- Lunit
- INFERVISION TECHNOLOGY
- Aidoc
- VUNO, Inc.
- ANNALISE-AI PTY LTD
- BioMind
- YITU Technology
- Shukun Technology
- Beijing Huiyi Huiying Medical Technology
- Shenzhen Keya Medical Technology
- Densitas
- Volpara
- Niramai
- MVision AI
- MammoScreen
- Perimeter Medical Imaging AI
- ICAD
- LungLifeAI
- Nanox.AI
- Varian Medical Systems
- Canon Medical
- GE Healthcare
- Philips
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artificial Intelligence (AI) in Cancer Market Size (2021-2032)
2.1.2 Artificial Intelligence (AI) in Cancer Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Artificial Intelligence (AI) in Cancer by Country/Region (2021, 2025 & 2032)
2.2 Artificial Intelligence (AI) in Cancer Segment by Type
2.2.1 Medical Imaging–based AI
2.2.2 Digital Pathology–based AI
2.2.3 Genomics & Multi-omics AI
2.2.4 Others
2.2.5 Artificial Intelligence (AI) in Cancer Market Size by Type
2.2.5.1 Artificial Intelligence (AI) in Cancer Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Artificial Intelligence (AI) in Cancer Market Size Market Share by Type (2021-2026)
2.3 Artificial Intelligence (AI) in Cancer Segment by AI Function Depth
2.3.1 Detection & Flagging
2.3.2 Segmentation & Quantification
2.3.3 Classification & Grading
2.3.4 Prediction & Outcome Modeling
2.3.5 Others
2.3.6 Artificial Intelligence (AI) in Cancer Market Size by AI Function Depth
2.3.6.1 Artificial Intelligence (AI) in Cancer Market Size CAGR by AI Function Depth (2021 VS 2025 VS 2032)
2.3.6.2 Global Artificial Intelligence (AI) in Cancer Market Size Market Share by AI Function Depth (2021-2026)
2.4 Artificial Intelligence (AI) in Cancer Segment by Product Form & Commercial Model
2.4.1 Device-embedded AI Systems
2.4.2 Standalone Software / SaaS Platforms
2.4.3 AI-as-a-Service for Oncology
2.4.4 Others
2.4.5 Artificial Intelligence (AI) in Cancer Market Size by Product Form & Commercial Model
2.4.5.1 Artificial Intelligence (AI) in Cancer Market Size CAGR by Product Form & Commercial Model (2021 VS 2025 VS 2032)
2.4.5.2 Global Artificial Intelligence (AI) in Cancer Market Size Market Share by Product Form & Commercial Model (2021-2026)
2.5 Artificial Intelligence (AI) in Cancer Segment by Application
2.5.1 Lung Cancer
2.5.2 Breast Cancer
2.5.3 Colorectal & GI Cancers
2.5.4 Prostate & Urological Cancers
2.5.5 Hematologic & Rare Cancers
2.5.6 Others
2.5.7 Artificial Intelligence (AI) in Cancer Market Size by Application
2.5.7.1 Artificial Intelligence (AI) in Cancer Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.7.2 Global Artificial Intelligence (AI) in Cancer Market Size Market Share by Application (2021-2026)
3 ARTIFICIAL INTELLIGENCE (AI) IN CANCER MARKET SIZE BY PLAYER
3.1 Artificial Intelligence (AI) in Cancer Market Size Market Share by Player
3.1.1 Global Artificial Intelligence (AI) in Cancer Revenue by Player (2021-2026)
3.1.2 Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Player (2021-2026)
3.2 Global Artificial Intelligence (AI) in Cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ARTIFICIAL INTELLIGENCE (AI) IN CANCER BY REGION
4.1 Artificial Intelligence (AI) in Cancer Market Size by Region (2021-2026)
4.2 Global Artificial Intelligence (AI) in Cancer Annual Revenue by Country/Region (2021-2026)
4.3 Americas Artificial Intelligence (AI) in Cancer Market Size Growth (2021-2026)
4.4 APAC Artificial Intelligence (AI) in Cancer Market Size Growth (2021-2026)
4.5 Europe Artificial Intelligence (AI) in Cancer Market Size Growth (2021-2026)
4.6 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Artificial Intelligence (AI) in Cancer Market Size by Country (2021-2026)
5.2 Americas Artificial Intelligence (AI) in Cancer Market Size by Type (2021-2026)
5.3 Americas Artificial Intelligence (AI) in Cancer Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Intelligence (AI) in Cancer Market Size by Region (2021-2026)
6.2 APAC Artificial Intelligence (AI) in Cancer Market Size by Type (2021-2026)
6.3 APAC Artificial Intelligence (AI) in Cancer Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2021-2026)
7.2 Europe Artificial Intelligence (AI) in Cancer Market Size by Type (2021-2026)
7.3 Europe Artificial Intelligence (AI) in Cancer Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artificial Intelligence (AI) in Cancer by Region (2021-2026)
8.2 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Type (2021-2026)
8.3 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN CANCER MARKET FORECAST
10.1 Global Artificial Intelligence (AI) in Cancer Forecast by Region (2027-2032)
10.1.1 Global Artificial Intelligence (AI) in Cancer Forecast by Region (2027-2032)
10.1.2 Americas Artificial Intelligence (AI) in Cancer Forecast
10.1.3 APAC Artificial Intelligence (AI) in Cancer Forecast
10.1.4 Europe Artificial Intelligence (AI) in Cancer Forecast
10.1.5 Middle East & Africa Artificial Intelligence (AI) in Cancer Forecast
10.2 Americas Artificial Intelligence (AI) in Cancer Forecast by Country (2027-2032)
10.2.1 United States Market Artificial Intelligence (AI) in Cancer Forecast
10.2.2 Canada Market Artificial Intelligence (AI) in Cancer Forecast
10.2.3 Mexico Market Artificial Intelligence (AI) in Cancer Forecast
10.2.4 Brazil Market Artificial Intelligence (AI) in Cancer Forecast
10.3 APAC Artificial Intelligence (AI) in Cancer Forecast by Region (2027-2032)
10.3.1 China Artificial Intelligence (AI) in Cancer Market Forecast
10.3.2 Japan Market Artificial Intelligence (AI) in Cancer Forecast
10.3.3 Korea Market Artificial Intelligence (AI) in Cancer Forecast
10.3.4 Southeast Asia Market Artificial Intelligence (AI) in Cancer Forecast
10.3.5 India Market Artificial Intelligence (AI) in Cancer Forecast
10.3.6 Australia Market Artificial Intelligence (AI) in Cancer Forecast
10.4 Europe Artificial Intelligence (AI) in Cancer Forecast by Country (2027-2032)
10.4.1 Germany Market Artificial Intelligence (AI) in Cancer Forecast
10.4.2 France Market Artificial Intelligence (AI) in Cancer Forecast
10.4.3 UK Market Artificial Intelligence (AI) in Cancer Forecast
10.4.4 Italy Market Artificial Intelligence (AI) in Cancer Forecast
10.4.5 Russia Market Artificial Intelligence (AI) in Cancer Forecast
10.5 Middle East & Africa Artificial Intelligence (AI) in Cancer Forecast by Region (2027-2032)
10.5.1 Egypt Market Artificial Intelligence (AI) in Cancer Forecast
10.5.2 South Africa Market Artificial Intelligence (AI) in Cancer Forecast
10.5.3 Israel Market Artificial Intelligence (AI) in Cancer Forecast
10.5.4 Turkey Market Artificial Intelligence (AI) in Cancer Forecast
10.6 Global Artificial Intelligence (AI) in Cancer Forecast by Type (2027-2032)
10.7 Global Artificial Intelligence (AI) in Cancer Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Artificial Intelligence (AI) in Cancer Forecast
11 KEY PLAYERS ANALYSIS
11.1 PathAI
11.1.1 PathAI Company Information
11.1.2 PathAI Artificial Intelligence (AI) in Cancer Product Offered
11.1.3 PathAI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 PathAI Main Business Overview
11.1.5 PathAI Latest Developments
11.2 PaigeAI
11.2.1 PaigeAI Company Information
11.2.2 PaigeAI Artificial Intelligence (AI) in Cancer Product Offered
11.2.3 PaigeAI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 PaigeAI Main Business Overview
11.2.5 PaigeAI Latest Developments
11.3 Lunit
11.3.1 Lunit Company Information
11.3.2 Lunit Artificial Intelligence (AI) in Cancer Product Offered
11.3.3 Lunit Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Lunit Main Business Overview
11.3.5 Lunit Latest Developments
11.4 INFERVISION TECHNOLOGY
11.4.1 INFERVISION TECHNOLOGY Company Information
11.4.2 INFERVISION TECHNOLOGY Artificial Intelligence (AI) in Cancer Product Offered
11.4.3 INFERVISION TECHNOLOGY Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 INFERVISION TECHNOLOGY Main Business Overview
11.4.5 INFERVISION TECHNOLOGY Latest Developments
11.5 Aidoc
11.5.1 Aidoc Company Information
11.5.2 Aidoc Artificial Intelligence (AI) in Cancer Product Offered
11.5.3 Aidoc Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Aidoc Main Business Overview
11.5.5 Aidoc Latest Developments
11.6 VUNO, Inc.
11.6.1 VUNO, Inc. Company Information
11.6.2 VUNO, Inc. Artificial Intelligence (AI) in Cancer Product Offered
11.6.3 VUNO, Inc. Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 VUNO, Inc. Main Business Overview
11.6.5 VUNO, Inc. Latest Developments
11.7 ANNALISE-AI PTY LTD
11.7.1 ANNALISE-AI PTY LTD Company Information
11.7.2 ANNALISE-AI PTY LTD Artificial Intelligence (AI) in Cancer Product Offered
11.7.3 ANNALISE-AI PTY LTD Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 ANNALISE-AI PTY LTD Main Business Overview
11.7.5 ANNALISE-AI PTY LTD Latest Developments
11.8 BioMind
11.8.1 BioMind Company Information
11.8.2 BioMind Artificial Intelligence (AI) in Cancer Product Offered
11.8.3 BioMind Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 BioMind Main Business Overview
11.8.5 BioMind Latest Developments
11.9 YITU Technology
11.9.1 YITU Technology Company Information
11.9.2 YITU Technology Artificial Intelligence (AI) in Cancer Product Offered
11.9.3 YITU Technology Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 YITU Technology Main Business Overview
11.9.5 YITU Technology Latest Developments
11.10 Shukun Technology
11.10.1 Shukun Technology Company Information
11.10.2 Shukun Technology Artificial Intelligence (AI) in Cancer Product Offered
11.10.3 Shukun Technology Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Shukun Technology Main Business Overview
11.10.5 Shukun Technology Latest Developments
11.11 Beijing Huiyi Huiying Medical Technology
11.11.1 Beijing Huiyi Huiying Medical Technology Company Information
11.11.2 Beijing Huiyi Huiying Medical Technology Artificial Intelligence (AI) in Cancer Product Offered
11.11.3 Beijing Huiyi Huiying Medical Technology Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Beijing Huiyi Huiying Medical Technology Main Business Overview
11.11.5 Beijing Huiyi Huiying Medical Technology Latest Developments
11.12 Shenzhen Keya Medical Technology
11.12.1 Shenzhen Keya Medical Technology Company Information
11.12.2 Shenzhen Keya Medical Technology Artificial Intelligence (AI) in Cancer Product Offered
11.12.3 Shenzhen Keya Medical Technology Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Shenzhen Keya Medical Technology Main Business Overview
11.12.5 Shenzhen Keya Medical Technology Latest Developments
11.13 Densitas
11.13.1 Densitas Company Information
11.13.2 Densitas Artificial Intelligence (AI) in Cancer Product Offered
11.13.3 Densitas Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Densitas Main Business Overview
11.13.5 Densitas Latest Developments
11.14 Volpara
11.14.1 Volpara Company Information
11.14.2 Volpara Artificial Intelligence (AI) in Cancer Product Offered
11.14.3 Volpara Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Volpara Main Business Overview
11.14.5 Volpara Latest Developments
11.15 Niramai
11.15.1 Niramai Company Information
11.15.2 Niramai Artificial Intelligence (AI) in Cancer Product Offered
11.15.3 Niramai Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Niramai Main Business Overview
11.15.5 Niramai Latest Developments
11.16 MVision AI
11.16.1 MVision AI Company Information
11.16.2 MVision AI Artificial Intelligence (AI) in Cancer Product Offered
11.16.3 MVision AI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 MVision AI Main Business Overview
11.16.5 MVision AI Latest Developments
11.17 MammoScreen
11.17.1 MammoScreen Company Information
11.17.2 MammoScreen Artificial Intelligence (AI) in Cancer Product Offered
11.17.3 MammoScreen Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 MammoScreen Main Business Overview
11.17.5 MammoScreen Latest Developments
11.18 Perimeter Medical Imaging AI
11.18.1 Perimeter Medical Imaging AI Company Information
11.18.2 Perimeter Medical Imaging AI Artificial Intelligence (AI) in Cancer Product Offered
11.18.3 Perimeter Medical Imaging AI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Perimeter Medical Imaging AI Main Business Overview
11.18.5 Perimeter Medical Imaging AI Latest Developments
11.19 ICAD
11.19.1 ICAD Company Information
11.19.2 ICAD Artificial Intelligence (AI) in Cancer Product Offered
11.19.3 ICAD Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 ICAD Main Business Overview
11.19.5 ICAD Latest Developments
11.20 LungLifeAI
11.20.1 LungLifeAI Company Information
11.20.2 LungLifeAI Artificial Intelligence (AI) in Cancer Product Offered
11.20.3 LungLifeAI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 LungLifeAI Main Business Overview
11.20.5 LungLifeAI Latest Developments
11.21 Nanox.AI
11.21.1 Nanox.AI Company Information
11.21.2 Nanox.AI Artificial Intelligence (AI) in Cancer Product Offered
11.21.3 Nanox.AI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Nanox.AI Main Business Overview
11.21.5 Nanox.AI Latest Developments
11.22 Varian Medical Systems
11.22.1 Varian Medical Systems Company Information
11.22.2 Varian Medical Systems Artificial Intelligence (AI) in Cancer Product Offered
11.22.3 Varian Medical Systems Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Varian Medical Systems Main Business Overview
11.22.5 Varian Medical Systems Latest Developments
11.23 Canon Medical
11.23.1 Canon Medical Company Information
11.23.2 Canon Medical Artificial Intelligence (AI) in Cancer Product Offered
11.23.3 Canon Medical Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Canon Medical Main Business Overview
11.23.5 Canon Medical Latest Developments
11.24 GE Healthcare
11.24.1 GE Healthcare Company Information
11.24.2 GE Healthcare Artificial Intelligence (AI) in Cancer Product Offered
11.24.3 GE Healthcare Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 GE Healthcare Main Business Overview
11.24.5 GE Healthcare Latest Developments
11.25 Philips
11.25.1 Philips Company Information
11.25.2 Philips Artificial Intelligence (AI) in Cancer Product Offered
11.25.3 Philips Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 Philips Main Business Overview
11.25.5 Philips Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artificial Intelligence (AI) in Cancer Market Size (2021-2032)
2.1.2 Artificial Intelligence (AI) in Cancer Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Artificial Intelligence (AI) in Cancer by Country/Region (2021, 2025 & 2032)
2.2 Artificial Intelligence (AI) in Cancer Segment by Type
2.2.1 Medical Imaging–based AI
2.2.2 Digital Pathology–based AI
2.2.3 Genomics & Multi-omics AI
2.2.4 Others
2.2.5 Artificial Intelligence (AI) in Cancer Market Size by Type
2.2.5.1 Artificial Intelligence (AI) in Cancer Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Artificial Intelligence (AI) in Cancer Market Size Market Share by Type (2021-2026)
2.3 Artificial Intelligence (AI) in Cancer Segment by AI Function Depth
2.3.1 Detection & Flagging
2.3.2 Segmentation & Quantification
2.3.3 Classification & Grading
2.3.4 Prediction & Outcome Modeling
2.3.5 Others
2.3.6 Artificial Intelligence (AI) in Cancer Market Size by AI Function Depth
2.3.6.1 Artificial Intelligence (AI) in Cancer Market Size CAGR by AI Function Depth (2021 VS 2025 VS 2032)
2.3.6.2 Global Artificial Intelligence (AI) in Cancer Market Size Market Share by AI Function Depth (2021-2026)
2.4 Artificial Intelligence (AI) in Cancer Segment by Product Form & Commercial Model
2.4.1 Device-embedded AI Systems
2.4.2 Standalone Software / SaaS Platforms
2.4.3 AI-as-a-Service for Oncology
2.4.4 Others
2.4.5 Artificial Intelligence (AI) in Cancer Market Size by Product Form & Commercial Model
2.4.5.1 Artificial Intelligence (AI) in Cancer Market Size CAGR by Product Form & Commercial Model (2021 VS 2025 VS 2032)
2.4.5.2 Global Artificial Intelligence (AI) in Cancer Market Size Market Share by Product Form & Commercial Model (2021-2026)
2.5 Artificial Intelligence (AI) in Cancer Segment by Application
2.5.1 Lung Cancer
2.5.2 Breast Cancer
2.5.3 Colorectal & GI Cancers
2.5.4 Prostate & Urological Cancers
2.5.5 Hematologic & Rare Cancers
2.5.6 Others
2.5.7 Artificial Intelligence (AI) in Cancer Market Size by Application
2.5.7.1 Artificial Intelligence (AI) in Cancer Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.7.2 Global Artificial Intelligence (AI) in Cancer Market Size Market Share by Application (2021-2026)
3 ARTIFICIAL INTELLIGENCE (AI) IN CANCER MARKET SIZE BY PLAYER
3.1 Artificial Intelligence (AI) in Cancer Market Size Market Share by Player
3.1.1 Global Artificial Intelligence (AI) in Cancer Revenue by Player (2021-2026)
3.1.2 Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Player (2021-2026)
3.2 Global Artificial Intelligence (AI) in Cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ARTIFICIAL INTELLIGENCE (AI) IN CANCER BY REGION
4.1 Artificial Intelligence (AI) in Cancer Market Size by Region (2021-2026)
4.2 Global Artificial Intelligence (AI) in Cancer Annual Revenue by Country/Region (2021-2026)
4.3 Americas Artificial Intelligence (AI) in Cancer Market Size Growth (2021-2026)
4.4 APAC Artificial Intelligence (AI) in Cancer Market Size Growth (2021-2026)
4.5 Europe Artificial Intelligence (AI) in Cancer Market Size Growth (2021-2026)
4.6 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Artificial Intelligence (AI) in Cancer Market Size by Country (2021-2026)
5.2 Americas Artificial Intelligence (AI) in Cancer Market Size by Type (2021-2026)
5.3 Americas Artificial Intelligence (AI) in Cancer Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Intelligence (AI) in Cancer Market Size by Region (2021-2026)
6.2 APAC Artificial Intelligence (AI) in Cancer Market Size by Type (2021-2026)
6.3 APAC Artificial Intelligence (AI) in Cancer Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2021-2026)
7.2 Europe Artificial Intelligence (AI) in Cancer Market Size by Type (2021-2026)
7.3 Europe Artificial Intelligence (AI) in Cancer Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artificial Intelligence (AI) in Cancer by Region (2021-2026)
8.2 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Type (2021-2026)
8.3 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN CANCER MARKET FORECAST
10.1 Global Artificial Intelligence (AI) in Cancer Forecast by Region (2027-2032)
10.1.1 Global Artificial Intelligence (AI) in Cancer Forecast by Region (2027-2032)
10.1.2 Americas Artificial Intelligence (AI) in Cancer Forecast
10.1.3 APAC Artificial Intelligence (AI) in Cancer Forecast
10.1.4 Europe Artificial Intelligence (AI) in Cancer Forecast
10.1.5 Middle East & Africa Artificial Intelligence (AI) in Cancer Forecast
10.2 Americas Artificial Intelligence (AI) in Cancer Forecast by Country (2027-2032)
10.2.1 United States Market Artificial Intelligence (AI) in Cancer Forecast
10.2.2 Canada Market Artificial Intelligence (AI) in Cancer Forecast
10.2.3 Mexico Market Artificial Intelligence (AI) in Cancer Forecast
10.2.4 Brazil Market Artificial Intelligence (AI) in Cancer Forecast
10.3 APAC Artificial Intelligence (AI) in Cancer Forecast by Region (2027-2032)
10.3.1 China Artificial Intelligence (AI) in Cancer Market Forecast
10.3.2 Japan Market Artificial Intelligence (AI) in Cancer Forecast
10.3.3 Korea Market Artificial Intelligence (AI) in Cancer Forecast
10.3.4 Southeast Asia Market Artificial Intelligence (AI) in Cancer Forecast
10.3.5 India Market Artificial Intelligence (AI) in Cancer Forecast
10.3.6 Australia Market Artificial Intelligence (AI) in Cancer Forecast
10.4 Europe Artificial Intelligence (AI) in Cancer Forecast by Country (2027-2032)
10.4.1 Germany Market Artificial Intelligence (AI) in Cancer Forecast
10.4.2 France Market Artificial Intelligence (AI) in Cancer Forecast
10.4.3 UK Market Artificial Intelligence (AI) in Cancer Forecast
10.4.4 Italy Market Artificial Intelligence (AI) in Cancer Forecast
10.4.5 Russia Market Artificial Intelligence (AI) in Cancer Forecast
10.5 Middle East & Africa Artificial Intelligence (AI) in Cancer Forecast by Region (2027-2032)
10.5.1 Egypt Market Artificial Intelligence (AI) in Cancer Forecast
10.5.2 South Africa Market Artificial Intelligence (AI) in Cancer Forecast
10.5.3 Israel Market Artificial Intelligence (AI) in Cancer Forecast
10.5.4 Turkey Market Artificial Intelligence (AI) in Cancer Forecast
10.6 Global Artificial Intelligence (AI) in Cancer Forecast by Type (2027-2032)
10.7 Global Artificial Intelligence (AI) in Cancer Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Artificial Intelligence (AI) in Cancer Forecast
11 KEY PLAYERS ANALYSIS
11.1 PathAI
11.1.1 PathAI Company Information
11.1.2 PathAI Artificial Intelligence (AI) in Cancer Product Offered
11.1.3 PathAI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 PathAI Main Business Overview
11.1.5 PathAI Latest Developments
11.2 PaigeAI
11.2.1 PaigeAI Company Information
11.2.2 PaigeAI Artificial Intelligence (AI) in Cancer Product Offered
11.2.3 PaigeAI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 PaigeAI Main Business Overview
11.2.5 PaigeAI Latest Developments
11.3 Lunit
11.3.1 Lunit Company Information
11.3.2 Lunit Artificial Intelligence (AI) in Cancer Product Offered
11.3.3 Lunit Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Lunit Main Business Overview
11.3.5 Lunit Latest Developments
11.4 INFERVISION TECHNOLOGY
11.4.1 INFERVISION TECHNOLOGY Company Information
11.4.2 INFERVISION TECHNOLOGY Artificial Intelligence (AI) in Cancer Product Offered
11.4.3 INFERVISION TECHNOLOGY Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 INFERVISION TECHNOLOGY Main Business Overview
11.4.5 INFERVISION TECHNOLOGY Latest Developments
11.5 Aidoc
11.5.1 Aidoc Company Information
11.5.2 Aidoc Artificial Intelligence (AI) in Cancer Product Offered
11.5.3 Aidoc Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Aidoc Main Business Overview
11.5.5 Aidoc Latest Developments
11.6 VUNO, Inc.
11.6.1 VUNO, Inc. Company Information
11.6.2 VUNO, Inc. Artificial Intelligence (AI) in Cancer Product Offered
11.6.3 VUNO, Inc. Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 VUNO, Inc. Main Business Overview
11.6.5 VUNO, Inc. Latest Developments
11.7 ANNALISE-AI PTY LTD
11.7.1 ANNALISE-AI PTY LTD Company Information
11.7.2 ANNALISE-AI PTY LTD Artificial Intelligence (AI) in Cancer Product Offered
11.7.3 ANNALISE-AI PTY LTD Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 ANNALISE-AI PTY LTD Main Business Overview
11.7.5 ANNALISE-AI PTY LTD Latest Developments
11.8 BioMind
11.8.1 BioMind Company Information
11.8.2 BioMind Artificial Intelligence (AI) in Cancer Product Offered
11.8.3 BioMind Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 BioMind Main Business Overview
11.8.5 BioMind Latest Developments
11.9 YITU Technology
11.9.1 YITU Technology Company Information
11.9.2 YITU Technology Artificial Intelligence (AI) in Cancer Product Offered
11.9.3 YITU Technology Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 YITU Technology Main Business Overview
11.9.5 YITU Technology Latest Developments
11.10 Shukun Technology
11.10.1 Shukun Technology Company Information
11.10.2 Shukun Technology Artificial Intelligence (AI) in Cancer Product Offered
11.10.3 Shukun Technology Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Shukun Technology Main Business Overview
11.10.5 Shukun Technology Latest Developments
11.11 Beijing Huiyi Huiying Medical Technology
11.11.1 Beijing Huiyi Huiying Medical Technology Company Information
11.11.2 Beijing Huiyi Huiying Medical Technology Artificial Intelligence (AI) in Cancer Product Offered
11.11.3 Beijing Huiyi Huiying Medical Technology Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Beijing Huiyi Huiying Medical Technology Main Business Overview
11.11.5 Beijing Huiyi Huiying Medical Technology Latest Developments
11.12 Shenzhen Keya Medical Technology
11.12.1 Shenzhen Keya Medical Technology Company Information
11.12.2 Shenzhen Keya Medical Technology Artificial Intelligence (AI) in Cancer Product Offered
11.12.3 Shenzhen Keya Medical Technology Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Shenzhen Keya Medical Technology Main Business Overview
11.12.5 Shenzhen Keya Medical Technology Latest Developments
11.13 Densitas
11.13.1 Densitas Company Information
11.13.2 Densitas Artificial Intelligence (AI) in Cancer Product Offered
11.13.3 Densitas Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Densitas Main Business Overview
11.13.5 Densitas Latest Developments
11.14 Volpara
11.14.1 Volpara Company Information
11.14.2 Volpara Artificial Intelligence (AI) in Cancer Product Offered
11.14.3 Volpara Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Volpara Main Business Overview
11.14.5 Volpara Latest Developments
11.15 Niramai
11.15.1 Niramai Company Information
11.15.2 Niramai Artificial Intelligence (AI) in Cancer Product Offered
11.15.3 Niramai Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Niramai Main Business Overview
11.15.5 Niramai Latest Developments
11.16 MVision AI
11.16.1 MVision AI Company Information
11.16.2 MVision AI Artificial Intelligence (AI) in Cancer Product Offered
11.16.3 MVision AI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 MVision AI Main Business Overview
11.16.5 MVision AI Latest Developments
11.17 MammoScreen
11.17.1 MammoScreen Company Information
11.17.2 MammoScreen Artificial Intelligence (AI) in Cancer Product Offered
11.17.3 MammoScreen Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 MammoScreen Main Business Overview
11.17.5 MammoScreen Latest Developments
11.18 Perimeter Medical Imaging AI
11.18.1 Perimeter Medical Imaging AI Company Information
11.18.2 Perimeter Medical Imaging AI Artificial Intelligence (AI) in Cancer Product Offered
11.18.3 Perimeter Medical Imaging AI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Perimeter Medical Imaging AI Main Business Overview
11.18.5 Perimeter Medical Imaging AI Latest Developments
11.19 ICAD
11.19.1 ICAD Company Information
11.19.2 ICAD Artificial Intelligence (AI) in Cancer Product Offered
11.19.3 ICAD Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 ICAD Main Business Overview
11.19.5 ICAD Latest Developments
11.20 LungLifeAI
11.20.1 LungLifeAI Company Information
11.20.2 LungLifeAI Artificial Intelligence (AI) in Cancer Product Offered
11.20.3 LungLifeAI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 LungLifeAI Main Business Overview
11.20.5 LungLifeAI Latest Developments
11.21 Nanox.AI
11.21.1 Nanox.AI Company Information
11.21.2 Nanox.AI Artificial Intelligence (AI) in Cancer Product Offered
11.21.3 Nanox.AI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Nanox.AI Main Business Overview
11.21.5 Nanox.AI Latest Developments
11.22 Varian Medical Systems
11.22.1 Varian Medical Systems Company Information
11.22.2 Varian Medical Systems Artificial Intelligence (AI) in Cancer Product Offered
11.22.3 Varian Medical Systems Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Varian Medical Systems Main Business Overview
11.22.5 Varian Medical Systems Latest Developments
11.23 Canon Medical
11.23.1 Canon Medical Company Information
11.23.2 Canon Medical Artificial Intelligence (AI) in Cancer Product Offered
11.23.3 Canon Medical Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Canon Medical Main Business Overview
11.23.5 Canon Medical Latest Developments
11.24 GE Healthcare
11.24.1 GE Healthcare Company Information
11.24.2 GE Healthcare Artificial Intelligence (AI) in Cancer Product Offered
11.24.3 GE Healthcare Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 GE Healthcare Main Business Overview
11.24.5 GE Healthcare Latest Developments
11.25 Philips
11.25.1 Philips Company Information
11.25.2 Philips Artificial Intelligence (AI) in Cancer Product Offered
11.25.3 Philips Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 Philips Main Business Overview
11.25.5 Philips Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Artificial Intelligence (AI) in Cancer Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Artificial Intelligence (AI) in Cancer Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Medical Imaging–based AI
Table 4. Major Players of Digital Pathology–based AI
Table 5. Major Players of Genomics & Multi-omics AI
Table 6. Major Players of Others
Table 7. Artificial Intelligence (AI) in Cancer Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Artificial Intelligence (AI) in Cancer Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Artificial Intelligence (AI) in Cancer Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Detection & Flagging
Table 11. Major Players of Segmentation & Quantification
Table 12. Major Players of Classification & Grading
Table 13. Major Players of Prediction & Outcome Modeling
Table 14. Major Players of Others
Table 15. Artificial Intelligence (AI) in Cancer Market Size CAGR by AI Function Depth (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global Artificial Intelligence (AI) in Cancer Market Size by AI Function Depth (2021-2026) & ($ millions)
Table 17. Global Artificial Intelligence (AI) in Cancer Market Size Market Share by AI Function Depth (2021-2026)
Table 18. Major Players of Device-embedded AI Systems
Table 19. Major Players of Standalone Software / SaaS Platforms
Table 20. Major Players of AI-as-a-Service for Oncology
Table 21. Major Players of Others
Table 22. Artificial Intelligence (AI) in Cancer Market Size CAGR by Product Form & Commercial Model (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Artificial Intelligence (AI) in Cancer Market Size by Product Form & Commercial Model (2021-2026) & ($ millions)
Table 24. Global Artificial Intelligence (AI) in Cancer Market Size Market Share by Product Form & Commercial Model (2021-2026)
Table 25. Artificial Intelligence (AI) in Cancer Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 26. Global Artificial Intelligence (AI) in Cancer Market Size by Application (2021-2026) & ($ millions)
Table 27. Global Artificial Intelligence (AI) in Cancer Market Size Market Share by Application (2021-2026)
Table 28. Global Artificial Intelligence (AI) in Cancer Revenue by Player (2021-2026) & ($ millions)
Table 29. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Player (2021-2026)
Table 30. Artificial Intelligence (AI) in Cancer Key Players Head office and Products Offered
Table 31. Artificial Intelligence (AI) in Cancer Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 32. New Products and Potential Entrants
Table 33. Mergers & Acquisitions, Expansion
Table 34. Global Artificial Intelligence (AI) in Cancer Market Size by Region (2021-2026) & ($ millions)
Table 35. Global Artificial Intelligence (AI) in Cancer Market Size Market Share by Region (2021-2026)
Table 36. Global Artificial Intelligence (AI) in Cancer Revenue by Country/Region (2021-2026) & ($ millions)
Table 37. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Country/Region (2021-2026)
Table 38. Americas Artificial Intelligence (AI) in Cancer Market Size by Country (2021-2026) & ($ millions)
Table 39. Americas Artificial Intelligence (AI) in Cancer Market Size Market Share by Country (2021-2026)
Table 40. Americas Artificial Intelligence (AI) in Cancer Market Size by Type (2021-2026) & ($ millions)
Table 41. Americas Artificial Intelligence (AI) in Cancer Market Size Market Share by Type (2021-2026)
Table 42. Americas Artificial Intelligence (AI) in Cancer Market Size by Application (2021-2026) & ($ millions)
Table 43. Americas Artificial Intelligence (AI) in Cancer Market Size Market Share by Application (2021-2026)
Table 44. APAC Artificial Intelligence (AI) in Cancer Market Size by Region (2021-2026) & ($ millions)
Table 45. APAC Artificial Intelligence (AI) in Cancer Market Size Market Share by Region (2021-2026)
Table 46. APAC Artificial Intelligence (AI) in Cancer Market Size by Type (2021-2026) & ($ millions)
Table 47. APAC Artificial Intelligence (AI) in Cancer Market Size by Application (2021-2026) & ($ millions)
Table 48. Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2021-2026) & ($ millions)
Table 49. Europe Artificial Intelligence (AI) in Cancer Market Size Market Share by Country (2021-2026)
Table 50. Europe Artificial Intelligence (AI) in Cancer Market Size by Type (2021-2026) & ($ millions)
Table 51. Europe Artificial Intelligence (AI) in Cancer Market Size by Application (2021-2026) & ($ millions)
Table 52. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Region (2021-2026) & ($ millions)
Table 53. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Type (2021-2026) & ($ millions)
Table 54. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Application (2021-2026) & ($ millions)
Table 55. Key Market Drivers & Growth Opportunities of Artificial Intelligence (AI) in Cancer
Table 56. Key Market Challenges & Risks of Artificial Intelligence (AI) in Cancer
Table 57. Key Industry Trends of Artificial Intelligence (AI) in Cancer
Table 58. Global Artificial Intelligence (AI) in Cancer Market Size Forecast by Region (2027-2032) & ($ millions)
Table 59. Global Artificial Intelligence (AI) in Cancer Market Size Market Share Forecast by Region (2027-2032)
Table 60. Global Artificial Intelligence (AI) in Cancer Market Size Forecast by Type (2027-2032) & ($ millions)
Table 61. Global Artificial Intelligence (AI) in Cancer Market Size Forecast by Application (2027-2032) & ($ millions)
Table 62. PathAI Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 63. PathAI Artificial Intelligence (AI) in Cancer Product Offered
Table 64. PathAI Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. PathAI Main Business
Table 66. PathAI Latest Developments
Table 67. PaigeAI Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 68. PaigeAI Artificial Intelligence (AI) in Cancer Product Offered
Table 69. PaigeAI Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. PaigeAI Main Business
Table 71. PaigeAI Latest Developments
Table 72. Lunit Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 73. Lunit Artificial Intelligence (AI) in Cancer Product Offered
Table 74. Lunit Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Lunit Main Business
Table 76. Lunit Latest Developments
Table 77. INFERVISION TECHNOLOGY Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 78. INFERVISION TECHNOLOGY Artificial Intelligence (AI) in Cancer Product Offered
Table 79. INFERVISION TECHNOLOGY Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. INFERVISION TECHNOLOGY Main Business
Table 81. INFERVISION TECHNOLOGY Latest Developments
Table 82. Aidoc Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 83. Aidoc Artificial Intelligence (AI) in Cancer Product Offered
Table 84. Aidoc Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Aidoc Main Business
Table 86. Aidoc Latest Developments
Table 87. VUNO, Inc. Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 88. VUNO, Inc. Artificial Intelligence (AI) in Cancer Product Offered
Table 89. VUNO, Inc. Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. VUNO, Inc. Main Business
Table 91. VUNO, Inc. Latest Developments
Table 92. ANNALISE-AI PTY LTD Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 93. ANNALISE-AI PTY LTD Artificial Intelligence (AI) in Cancer Product Offered
Table 94. ANNALISE-AI PTY LTD Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. ANNALISE-AI PTY LTD Main Business
Table 96. ANNALISE-AI PTY LTD Latest Developments
Table 97. BioMind Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 98. BioMind Artificial Intelligence (AI) in Cancer Product Offered
Table 99. BioMind Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. BioMind Main Business
Table 101. BioMind Latest Developments
Table 102. YITU Technology Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 103. YITU Technology Artificial Intelligence (AI) in Cancer Product Offered
Table 104. YITU Technology Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. YITU Technology Main Business
Table 106. YITU Technology Latest Developments
Table 107. Shukun Technology Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 108. Shukun Technology Artificial Intelligence (AI) in Cancer Product Offered
Table 109. Shukun Technology Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Shukun Technology Main Business
Table 111. Shukun Technology Latest Developments
Table 112. Beijing Huiyi Huiying Medical Technology Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 113. Beijing Huiyi Huiying Medical Technology Artificial Intelligence (AI) in Cancer Product Offered
Table 114. Beijing Huiyi Huiying Medical Technology Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Beijing Huiyi Huiying Medical Technology Main Business
Table 116. Beijing Huiyi Huiying Medical Technology Latest Developments
Table 117. Shenzhen Keya Medical Technology Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 118. Shenzhen Keya Medical Technology Artificial Intelligence (AI) in Cancer Product Offered
Table 119. Shenzhen Keya Medical Technology Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Shenzhen Keya Medical Technology Main Business
Table 121. Shenzhen Keya Medical Technology Latest Developments
Table 122. Densitas Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 123. Densitas Artificial Intelligence (AI) in Cancer Product Offered
Table 124. Densitas Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. Densitas Main Business
Table 126. Densitas Latest Developments
Table 127. Volpara Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 128. Volpara Artificial Intelligence (AI) in Cancer Product Offered
Table 129. Volpara Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. Volpara Main Business
Table 131. Volpara Latest Developments
Table 132. Niramai Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 133. Niramai Artificial Intelligence (AI) in Cancer Product Offered
Table 134. Niramai Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 135. Niramai Main Business
Table 136. Niramai Latest Developments
Table 137. MVision AI Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 138. MVision AI Artificial Intelligence (AI) in Cancer Product Offered
Table 139. MVision AI Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 140. MVision AI Main Business
Table 141. MVision AI Latest Developments
Table 142. MammoScreen Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 143. MammoScreen Artificial Intelligence (AI) in Cancer Product Offered
Table 144. MammoScreen Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 145. MammoScreen Main Business
Table 146. MammoScreen Latest Developments
Table 147. Perimeter Medical Imaging AI Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 148. Perimeter Medical Imaging AI Artificial Intelligence (AI) in Cancer Product Offered
Table 149. Perimeter Medical Imaging AI Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 150. Perimeter Medical Imaging AI Main Business
Table 151. Perimeter Medical Imaging AI Latest Developments
Table 152. ICAD Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 153. ICAD Artificial Intelligence (AI) in Cancer Product Offered
Table 154. ICAD Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 155. ICAD Main Business
Table 156. ICAD Latest Developments
Table 157. LungLifeAI Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 158. LungLifeAI Artificial Intelligence (AI) in Cancer Product Offered
Table 159. LungLifeAI Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 160. LungLifeAI Main Business
Table 161. LungLifeAI Latest Developments
Table 162. Nanox.AI Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 163. Nanox.AI Artificial Intelligence (AI) in Cancer Product Offered
Table 164. Nanox.AI Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 165. Nanox.AI Main Business
Table 166. Nanox.AI Latest Developments
Table 167. Varian Medical Systems Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 168. Varian Medical Systems Artificial Intelligence (AI) in Cancer Product Offered
Table 169. Varian Medical Systems Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 170. Varian Medical Systems Main Business
Table 171. Varian Medical Systems Latest Developments
Table 172. Canon Medical Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 173. Canon Medical Artificial Intelligence (AI) in Cancer Product Offered
Table 174. Canon Medical Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 175. Canon Medical Main Business
Table 176. Canon Medical Latest Developments
Table 177. GE Healthcare Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 178. GE Healthcare Artificial Intelligence (AI) in Cancer Product Offered
Table 179. GE Healthcare Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 180. GE Healthcare Main Business
Table 181. GE Healthcare Latest Developments
Table 182. Philips Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 183. Philips Artificial Intelligence (AI) in Cancer Product Offered
Table 184. Philips Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 185. Philips Main Business
Table 186. Philips Latest Developments
Table 1. Artificial Intelligence (AI) in Cancer Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Artificial Intelligence (AI) in Cancer Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Medical Imaging–based AI
Table 4. Major Players of Digital Pathology–based AI
Table 5. Major Players of Genomics & Multi-omics AI
Table 6. Major Players of Others
Table 7. Artificial Intelligence (AI) in Cancer Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Artificial Intelligence (AI) in Cancer Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Artificial Intelligence (AI) in Cancer Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Detection & Flagging
Table 11. Major Players of Segmentation & Quantification
Table 12. Major Players of Classification & Grading
Table 13. Major Players of Prediction & Outcome Modeling
Table 14. Major Players of Others
Table 15. Artificial Intelligence (AI) in Cancer Market Size CAGR by AI Function Depth (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global Artificial Intelligence (AI) in Cancer Market Size by AI Function Depth (2021-2026) & ($ millions)
Table 17. Global Artificial Intelligence (AI) in Cancer Market Size Market Share by AI Function Depth (2021-2026)
Table 18. Major Players of Device-embedded AI Systems
Table 19. Major Players of Standalone Software / SaaS Platforms
Table 20. Major Players of AI-as-a-Service for Oncology
Table 21. Major Players of Others
Table 22. Artificial Intelligence (AI) in Cancer Market Size CAGR by Product Form & Commercial Model (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Artificial Intelligence (AI) in Cancer Market Size by Product Form & Commercial Model (2021-2026) & ($ millions)
Table 24. Global Artificial Intelligence (AI) in Cancer Market Size Market Share by Product Form & Commercial Model (2021-2026)
Table 25. Artificial Intelligence (AI) in Cancer Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 26. Global Artificial Intelligence (AI) in Cancer Market Size by Application (2021-2026) & ($ millions)
Table 27. Global Artificial Intelligence (AI) in Cancer Market Size Market Share by Application (2021-2026)
Table 28. Global Artificial Intelligence (AI) in Cancer Revenue by Player (2021-2026) & ($ millions)
Table 29. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Player (2021-2026)
Table 30. Artificial Intelligence (AI) in Cancer Key Players Head office and Products Offered
Table 31. Artificial Intelligence (AI) in Cancer Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 32. New Products and Potential Entrants
Table 33. Mergers & Acquisitions, Expansion
Table 34. Global Artificial Intelligence (AI) in Cancer Market Size by Region (2021-2026) & ($ millions)
Table 35. Global Artificial Intelligence (AI) in Cancer Market Size Market Share by Region (2021-2026)
Table 36. Global Artificial Intelligence (AI) in Cancer Revenue by Country/Region (2021-2026) & ($ millions)
Table 37. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Country/Region (2021-2026)
Table 38. Americas Artificial Intelligence (AI) in Cancer Market Size by Country (2021-2026) & ($ millions)
Table 39. Americas Artificial Intelligence (AI) in Cancer Market Size Market Share by Country (2021-2026)
Table 40. Americas Artificial Intelligence (AI) in Cancer Market Size by Type (2021-2026) & ($ millions)
Table 41. Americas Artificial Intelligence (AI) in Cancer Market Size Market Share by Type (2021-2026)
Table 42. Americas Artificial Intelligence (AI) in Cancer Market Size by Application (2021-2026) & ($ millions)
Table 43. Americas Artificial Intelligence (AI) in Cancer Market Size Market Share by Application (2021-2026)
Table 44. APAC Artificial Intelligence (AI) in Cancer Market Size by Region (2021-2026) & ($ millions)
Table 45. APAC Artificial Intelligence (AI) in Cancer Market Size Market Share by Region (2021-2026)
Table 46. APAC Artificial Intelligence (AI) in Cancer Market Size by Type (2021-2026) & ($ millions)
Table 47. APAC Artificial Intelligence (AI) in Cancer Market Size by Application (2021-2026) & ($ millions)
Table 48. Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2021-2026) & ($ millions)
Table 49. Europe Artificial Intelligence (AI) in Cancer Market Size Market Share by Country (2021-2026)
Table 50. Europe Artificial Intelligence (AI) in Cancer Market Size by Type (2021-2026) & ($ millions)
Table 51. Europe Artificial Intelligence (AI) in Cancer Market Size by Application (2021-2026) & ($ millions)
Table 52. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Region (2021-2026) & ($ millions)
Table 53. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Type (2021-2026) & ($ millions)
Table 54. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Application (2021-2026) & ($ millions)
Table 55. Key Market Drivers & Growth Opportunities of Artificial Intelligence (AI) in Cancer
Table 56. Key Market Challenges & Risks of Artificial Intelligence (AI) in Cancer
Table 57. Key Industry Trends of Artificial Intelligence (AI) in Cancer
Table 58. Global Artificial Intelligence (AI) in Cancer Market Size Forecast by Region (2027-2032) & ($ millions)
Table 59. Global Artificial Intelligence (AI) in Cancer Market Size Market Share Forecast by Region (2027-2032)
Table 60. Global Artificial Intelligence (AI) in Cancer Market Size Forecast by Type (2027-2032) & ($ millions)
Table 61. Global Artificial Intelligence (AI) in Cancer Market Size Forecast by Application (2027-2032) & ($ millions)
Table 62. PathAI Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 63. PathAI Artificial Intelligence (AI) in Cancer Product Offered
Table 64. PathAI Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. PathAI Main Business
Table 66. PathAI Latest Developments
Table 67. PaigeAI Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 68. PaigeAI Artificial Intelligence (AI) in Cancer Product Offered
Table 69. PaigeAI Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. PaigeAI Main Business
Table 71. PaigeAI Latest Developments
Table 72. Lunit Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 73. Lunit Artificial Intelligence (AI) in Cancer Product Offered
Table 74. Lunit Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Lunit Main Business
Table 76. Lunit Latest Developments
Table 77. INFERVISION TECHNOLOGY Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 78. INFERVISION TECHNOLOGY Artificial Intelligence (AI) in Cancer Product Offered
Table 79. INFERVISION TECHNOLOGY Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. INFERVISION TECHNOLOGY Main Business
Table 81. INFERVISION TECHNOLOGY Latest Developments
Table 82. Aidoc Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 83. Aidoc Artificial Intelligence (AI) in Cancer Product Offered
Table 84. Aidoc Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Aidoc Main Business
Table 86. Aidoc Latest Developments
Table 87. VUNO, Inc. Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 88. VUNO, Inc. Artificial Intelligence (AI) in Cancer Product Offered
Table 89. VUNO, Inc. Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. VUNO, Inc. Main Business
Table 91. VUNO, Inc. Latest Developments
Table 92. ANNALISE-AI PTY LTD Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 93. ANNALISE-AI PTY LTD Artificial Intelligence (AI) in Cancer Product Offered
Table 94. ANNALISE-AI PTY LTD Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. ANNALISE-AI PTY LTD Main Business
Table 96. ANNALISE-AI PTY LTD Latest Developments
Table 97. BioMind Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 98. BioMind Artificial Intelligence (AI) in Cancer Product Offered
Table 99. BioMind Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. BioMind Main Business
Table 101. BioMind Latest Developments
Table 102. YITU Technology Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 103. YITU Technology Artificial Intelligence (AI) in Cancer Product Offered
Table 104. YITU Technology Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. YITU Technology Main Business
Table 106. YITU Technology Latest Developments
Table 107. Shukun Technology Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 108. Shukun Technology Artificial Intelligence (AI) in Cancer Product Offered
Table 109. Shukun Technology Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Shukun Technology Main Business
Table 111. Shukun Technology Latest Developments
Table 112. Beijing Huiyi Huiying Medical Technology Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 113. Beijing Huiyi Huiying Medical Technology Artificial Intelligence (AI) in Cancer Product Offered
Table 114. Beijing Huiyi Huiying Medical Technology Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Beijing Huiyi Huiying Medical Technology Main Business
Table 116. Beijing Huiyi Huiying Medical Technology Latest Developments
Table 117. Shenzhen Keya Medical Technology Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 118. Shenzhen Keya Medical Technology Artificial Intelligence (AI) in Cancer Product Offered
Table 119. Shenzhen Keya Medical Technology Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Shenzhen Keya Medical Technology Main Business
Table 121. Shenzhen Keya Medical Technology Latest Developments
Table 122. Densitas Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 123. Densitas Artificial Intelligence (AI) in Cancer Product Offered
Table 124. Densitas Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. Densitas Main Business
Table 126. Densitas Latest Developments
Table 127. Volpara Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 128. Volpara Artificial Intelligence (AI) in Cancer Product Offered
Table 129. Volpara Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. Volpara Main Business
Table 131. Volpara Latest Developments
Table 132. Niramai Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 133. Niramai Artificial Intelligence (AI) in Cancer Product Offered
Table 134. Niramai Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 135. Niramai Main Business
Table 136. Niramai Latest Developments
Table 137. MVision AI Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 138. MVision AI Artificial Intelligence (AI) in Cancer Product Offered
Table 139. MVision AI Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 140. MVision AI Main Business
Table 141. MVision AI Latest Developments
Table 142. MammoScreen Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 143. MammoScreen Artificial Intelligence (AI) in Cancer Product Offered
Table 144. MammoScreen Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 145. MammoScreen Main Business
Table 146. MammoScreen Latest Developments
Table 147. Perimeter Medical Imaging AI Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 148. Perimeter Medical Imaging AI Artificial Intelligence (AI) in Cancer Product Offered
Table 149. Perimeter Medical Imaging AI Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 150. Perimeter Medical Imaging AI Main Business
Table 151. Perimeter Medical Imaging AI Latest Developments
Table 152. ICAD Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 153. ICAD Artificial Intelligence (AI) in Cancer Product Offered
Table 154. ICAD Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 155. ICAD Main Business
Table 156. ICAD Latest Developments
Table 157. LungLifeAI Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 158. LungLifeAI Artificial Intelligence (AI) in Cancer Product Offered
Table 159. LungLifeAI Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 160. LungLifeAI Main Business
Table 161. LungLifeAI Latest Developments
Table 162. Nanox.AI Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 163. Nanox.AI Artificial Intelligence (AI) in Cancer Product Offered
Table 164. Nanox.AI Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 165. Nanox.AI Main Business
Table 166. Nanox.AI Latest Developments
Table 167. Varian Medical Systems Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 168. Varian Medical Systems Artificial Intelligence (AI) in Cancer Product Offered
Table 169. Varian Medical Systems Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 170. Varian Medical Systems Main Business
Table 171. Varian Medical Systems Latest Developments
Table 172. Canon Medical Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 173. Canon Medical Artificial Intelligence (AI) in Cancer Product Offered
Table 174. Canon Medical Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 175. Canon Medical Main Business
Table 176. Canon Medical Latest Developments
Table 177. GE Healthcare Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 178. GE Healthcare Artificial Intelligence (AI) in Cancer Product Offered
Table 179. GE Healthcare Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 180. GE Healthcare Main Business
Table 181. GE Healthcare Latest Developments
Table 182. Philips Details, Company Type, Artificial Intelligence (AI) in Cancer Area Served and Its Competitors
Table 183. Philips Artificial Intelligence (AI) in Cancer Product Offered
Table 184. Philips Artificial Intelligence (AI) in Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 185. Philips Main Business
Table 186. Philips Latest Developments
LIST OF FIGURES
Figure 1. Artificial Intelligence (AI) in Cancer Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Artificial Intelligence (AI) in Cancer Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Artificial Intelligence (AI) in Cancer Sales Market Share by Country/Region (2025)
Figure 8. Artificial Intelligence (AI) in Cancer Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Artificial Intelligence (AI) in Cancer Market Size Market Share by Type in 2025
Figure 10. Global Artificial Intelligence (AI) in Cancer Market Size Market Share by AI Function Depth in 2025
Figure 11. Global Artificial Intelligence (AI) in Cancer Market Size Market Share by Product Form & Commercial Model in 2025
Figure 12. Artificial Intelligence (AI) in Cancer in Lung Cancer
Figure 13. Global Artificial Intelligence (AI) in Cancer Market: Lung Cancer (2021-2026) & ($ millions)
Figure 14. Artificial Intelligence (AI) in Cancer in Breast Cancer
Figure 15. Global Artificial Intelligence (AI) in Cancer Market: Breast Cancer (2021-2026) & ($ millions)
Figure 16. Artificial Intelligence (AI) in Cancer in Colorectal & GI Cancers
Figure 17. Global Artificial Intelligence (AI) in Cancer Market: Colorectal & GI Cancers (2021-2026) & ($ millions)
Figure 18. Artificial Intelligence (AI) in Cancer in Prostate & Urological Cancers
Figure 19. Global Artificial Intelligence (AI) in Cancer Market: Prostate & Urological Cancers (2021-2026) & ($ millions)
Figure 20. Artificial Intelligence (AI) in Cancer in Hematologic & Rare Cancers
Figure 21. Global Artificial Intelligence (AI) in Cancer Market: Hematologic & Rare Cancers (2021-2026) & ($ millions)
Figure 22. Artificial Intelligence (AI) in Cancer in Others
Figure 23. Global Artificial Intelligence (AI) in Cancer Market: Others (2021-2026) & ($ millions)
Figure 24. Global Artificial Intelligence (AI) in Cancer Market Size Market Share by Application in 2025
Figure 25. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Player in 2025
Figure 26. Global Artificial Intelligence (AI) in Cancer Market Size Market Share by Region (2021-2026)
Figure 27. Americas Artificial Intelligence (AI) in Cancer Market Size 2021-2026 ($ millions)
Figure 28. APAC Artificial Intelligence (AI) in Cancer Market Size 2021-2026 ($ millions)
Figure 29. Europe Artificial Intelligence (AI) in Cancer Market Size 2021-2026 ($ millions)
Figure 30. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size 2021-2026 ($ millions)
Figure 31. Americas Artificial Intelligence (AI) in Cancer Value Market Share by Country in 2025
Figure 32. United States Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 33. Canada Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 34. Mexico Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 35. Brazil Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 36. APAC Artificial Intelligence (AI) in Cancer Market Size Market Share by Region in 2025
Figure 37. APAC Artificial Intelligence (AI) in Cancer Market Size Market Share by Type (2021-2026)
Figure 38. APAC Artificial Intelligence (AI) in Cancer Market Size Market Share by Application (2021-2026)
Figure 39. China Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 40. Japan Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 41. South Korea Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 42. Southeast Asia Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 43. India Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 44. Australia Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 45. Europe Artificial Intelligence (AI) in Cancer Market Size Market Share by Country in 2025
Figure 46. Europe Artificial Intelligence (AI) in Cancer Market Size Market Share by Type (2021-2026)
Figure 47. Europe Artificial Intelligence (AI) in Cancer Market Size Market Share by Application (2021-2026)
Figure 48. Germany Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 49. France Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 50. UK Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 51. Italy Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 52. Russia Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 53. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size Market Share by Region (2021-2026)
Figure 54. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size Market Share by Type (2021-2026)
Figure 55. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size Market Share by Application (2021-2026)
Figure 56. Egypt Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 57. South Africa Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 58. Israel Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 59. Turkey Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 60. GCC Countries Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 61. Americas Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 62. APAC Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 63. Europe Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 64. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 65. United States Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 66. Canada Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 67. Mexico Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 68. Brazil Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 69. China Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 70. Japan Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 71. Korea Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 72. Southeast Asia Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 73. India Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 74. Australia Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 75. Germany Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 76. France Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 77. UK Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 78. Italy Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 79. Russia Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 80. Egypt Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 81. South Africa Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 82. Israel Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 83. Turkey Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 84. Global Artificial Intelligence (AI) in Cancer Market Size Market Share Forecast by Type (2027-2032)
Figure 85. Global Artificial Intelligence (AI) in Cancer Market Size Market Share Forecast by Application (2027-2032)
Figure 86. GCC Countries Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 1. Artificial Intelligence (AI) in Cancer Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Artificial Intelligence (AI) in Cancer Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Artificial Intelligence (AI) in Cancer Sales Market Share by Country/Region (2025)
Figure 8. Artificial Intelligence (AI) in Cancer Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Artificial Intelligence (AI) in Cancer Market Size Market Share by Type in 2025
Figure 10. Global Artificial Intelligence (AI) in Cancer Market Size Market Share by AI Function Depth in 2025
Figure 11. Global Artificial Intelligence (AI) in Cancer Market Size Market Share by Product Form & Commercial Model in 2025
Figure 12. Artificial Intelligence (AI) in Cancer in Lung Cancer
Figure 13. Global Artificial Intelligence (AI) in Cancer Market: Lung Cancer (2021-2026) & ($ millions)
Figure 14. Artificial Intelligence (AI) in Cancer in Breast Cancer
Figure 15. Global Artificial Intelligence (AI) in Cancer Market: Breast Cancer (2021-2026) & ($ millions)
Figure 16. Artificial Intelligence (AI) in Cancer in Colorectal & GI Cancers
Figure 17. Global Artificial Intelligence (AI) in Cancer Market: Colorectal & GI Cancers (2021-2026) & ($ millions)
Figure 18. Artificial Intelligence (AI) in Cancer in Prostate & Urological Cancers
Figure 19. Global Artificial Intelligence (AI) in Cancer Market: Prostate & Urological Cancers (2021-2026) & ($ millions)
Figure 20. Artificial Intelligence (AI) in Cancer in Hematologic & Rare Cancers
Figure 21. Global Artificial Intelligence (AI) in Cancer Market: Hematologic & Rare Cancers (2021-2026) & ($ millions)
Figure 22. Artificial Intelligence (AI) in Cancer in Others
Figure 23. Global Artificial Intelligence (AI) in Cancer Market: Others (2021-2026) & ($ millions)
Figure 24. Global Artificial Intelligence (AI) in Cancer Market Size Market Share by Application in 2025
Figure 25. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Player in 2025
Figure 26. Global Artificial Intelligence (AI) in Cancer Market Size Market Share by Region (2021-2026)
Figure 27. Americas Artificial Intelligence (AI) in Cancer Market Size 2021-2026 ($ millions)
Figure 28. APAC Artificial Intelligence (AI) in Cancer Market Size 2021-2026 ($ millions)
Figure 29. Europe Artificial Intelligence (AI) in Cancer Market Size 2021-2026 ($ millions)
Figure 30. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size 2021-2026 ($ millions)
Figure 31. Americas Artificial Intelligence (AI) in Cancer Value Market Share by Country in 2025
Figure 32. United States Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 33. Canada Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 34. Mexico Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 35. Brazil Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 36. APAC Artificial Intelligence (AI) in Cancer Market Size Market Share by Region in 2025
Figure 37. APAC Artificial Intelligence (AI) in Cancer Market Size Market Share by Type (2021-2026)
Figure 38. APAC Artificial Intelligence (AI) in Cancer Market Size Market Share by Application (2021-2026)
Figure 39. China Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 40. Japan Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 41. South Korea Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 42. Southeast Asia Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 43. India Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 44. Australia Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 45. Europe Artificial Intelligence (AI) in Cancer Market Size Market Share by Country in 2025
Figure 46. Europe Artificial Intelligence (AI) in Cancer Market Size Market Share by Type (2021-2026)
Figure 47. Europe Artificial Intelligence (AI) in Cancer Market Size Market Share by Application (2021-2026)
Figure 48. Germany Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 49. France Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 50. UK Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 51. Italy Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 52. Russia Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 53. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size Market Share by Region (2021-2026)
Figure 54. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size Market Share by Type (2021-2026)
Figure 55. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size Market Share by Application (2021-2026)
Figure 56. Egypt Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 57. South Africa Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 58. Israel Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 59. Turkey Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 60. GCC Countries Artificial Intelligence (AI) in Cancer Market Size Growth 2021-2026 ($ millions)
Figure 61. Americas Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 62. APAC Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 63. Europe Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 64. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 65. United States Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 66. Canada Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 67. Mexico Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 68. Brazil Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 69. China Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 70. Japan Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 71. Korea Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 72. Southeast Asia Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 73. India Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 74. Australia Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 75. Germany Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 76. France Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 77. UK Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 78. Italy Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 79. Russia Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 80. Egypt Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 81. South Africa Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 82. Israel Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 83. Turkey Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
Figure 84. Global Artificial Intelligence (AI) in Cancer Market Size Market Share Forecast by Type (2027-2032)
Figure 85. Global Artificial Intelligence (AI) in Cancer Market Size Market Share Forecast by Application (2027-2032)
Figure 86. GCC Countries Artificial Intelligence (AI) in Cancer Market Size 2027-2032 ($ millions)
More Publications
Global DMSO-free Freezing Culture Media Market Growth 2024-2030
US$ 3,660.00
March 2024
113 pages
Global Sphingosine 1-Phosphate Receptor 1 Market Growth 2025-2031
US$ 3,660.00
January 2025
79 pages
Global Handheld Ultrasound Equipment Market Growth 2025-2031
US$ 3,660.00
January 2025
137 pages
Global Glaucoma Diagnostics Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
87 pages
Global Digital Electronic Thermometers Market Growth 2024-2030
US$ 3,660.00
December 2024
152 pages
